MedPath

YERVOY

YERVOY

Approved
DIN Number

02379384

Drug Class

Human

Market Date

Mar 8, 2012

Company
HC

bristol-myers squibb canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02379384
AIG Number0153088001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L01FX04 IPILIMUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

IPILIMUMABActive
Strength: 5 MG / ML
Monograph: IPILIMUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.